First-line CDK4/6 inhibitors fail to improve overall survival in advanced breast cancer. Lawrence L. Cancer 2026;132:e70441.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lawrence L. First-line CDK4/6 inhibitors fail to improve overall survival in advanced breast cancer. Cancer 2026;132:e70441.
PMID: 42316758